HighCape Capital Acquisition Corp.
CAPA · Nasdaq
NO ACTION REQUIRED
Nothing left to do
The purchase completed and the shares became shares in the company it bought. There is no deadline left to miss.
Cash at settlement
No cash-per-share figure was filed for this vehicle before it finished.
Last close
Daily close
No price history on file yet — daily closes accumulate from the market data feed.
Trust settled · There is no line to draw here. This vehicle has finished: the cash was paid back or spent closing the deal, so the last filed figure describes an account that no longer exists and would be a floor under nothing.
SpacBrain’s read
Trust settled
The deal closed — SPAC shares became the target's shares, so there is no trust left to redeem (nobody missed a window; holders who wanted cash elected it at the vote).
In plain terms
- What it is
- A SPAC from HighCape Capital Acquisition LLC, listed on Nasdaq in September 2020.
- What it's doing now
- It agreed to buy Quantum-Si Inc. That purchase completed, and it stopped being a SPAC — the shares became shares in the business it bought.
- What you should know
- This SPAC has finished. The purchase completed, and the shares became shares in the company it bought — anyone who wanted the cash instead asked for it at the vote, so there is no cash left here to claim and no deadline left to miss.
At a glance
- Where it stands
- Closed (deSPAC)
- The business it bought
- Quantum-Si Inc — Incorporated Quantum-Si is focused on revolutionizing the growing field of proteomics.
- Industry
- the deal record does not name the target's industry yet
- Deal value
- not stated in the filings we hold
- Price vs cash at settlement
- no live price on file
- Cash in trust when it settled
- not yet extracted into a snapshot — the filings below may state it
- the last trust total filed while this was still a SPAC — the account has since been paid out or used to close the deal
- IPO
- 4 September 2020
- size not on file
- Headquarters
- 29 BUSINESS PARK DRIVE, BRANFORD, CT, 06405
- registered in Delaware
- Lead underwriter
- not extracted from the prospectus yet
- Key officers
- Fattori Ruth A (Director) · LaPointe Christian (GC & Corp. Secretary) · Keyes Jeffry R. (Chief Financial Officer)
- Listed securities
- CAPA common
This vehicle has finished, so there is no window to file a cash-per-share figure for and none will follow. No estimate is shown in its place.
Nothing dated is on file. That is an absence in the record, not a statement that nothing is coming.
Yield to redemption
Nothing left to redeem — no yield to compute.
This SPAC has finished — its trust was paid back or used to close the deal, so there is nothing left to redeem and no yield to compute. A yield to redemption is a claim that you can hand these shares back for the trust cash. That account is closed, so this page will not print a number here.
What happened to the cash
The reasoning behind the verdict above, in the order the filings establish it.
- The deal closed — SPAC shares became the target's shares, so there is no trust left to redeem (nobody missed a window; holders who wanted cash elected it at the vote).
What has happened, and what is coming
1 dated milestoneEvery dated step from the day it listed to the next date you may have to act on. Where you have to do something, the day your broker needs the instruction is marked too.
- 4 September 2020IPOpassed
IPO size not on file
The deal
terms as filedWhat it is buying, on what terms, and how much of the combined company new shares take from you.
- closed
What Quantum-Si Inc does — read from quantum-si.com on 26 August 2026
Quantum-Si is a company founded in 2013 that pioneers single-molecule protein sequencing to make proteomics accessible. Their flagship product, the Platinum Pro, is a compact benchtop instrument that delivers single-amino-acid resolution without requiring dedicated lab space or bioinformatics expertise. The technology uses kinetic signatures to detect post-translational modifications, protein variants, and enables applications like antibody characterization and protein barcoding for drug development.
ProteomicsDrug DevelopmentResearchDeal structureSEC-primary — BCA 8-K / S-4 / DEFM14A- PIPE
- ≈ $425M · unsourced
- Break fee
- $11M
PIPE terms — instrument, coupon, conversion price and any reset floor — are not sourced for this deal. The size above is itself unsourced — a stored figure no filing we hold states — so neither the size nor the terms should be read as cited.
The score
deterministic, from filed fieldsCAPA is not in the scored universe, so no score is shown. A withheld score is a fact about the record, not a verdict about the company.
The score is only published for names that carry both a price and a filed cash-per-share figure — 292 of the tracked fleet today. The rest keep an empty dial rather than a modelled one, and fill in by themselves as the fields land.
The company
from SEC filingsRead the full profile
HighCape Capital Acquisition Corp. was a blank-check company whose common stock traded on the Nasdaq Stock Market under the ticker CAPA. The company priced its initial public offering on September 4, 2020, under SEC file number 333-240283, a registration of shares sold for cash on Form S-1 filed August 3, 2020. Its SEC filings classified it under SIC industry code 3829, Measuring & Controlling Devices, NEC, and the registrant described itself as a blank-check company in its 424B4 prospectus. The vehicle completed a business combination and no longer files as a separate entity; an 8-K filed June 15, 2021 reported a change in shell company status under item 5.06, and EDGAR now files CIK 0001816431 under the name Quantum-Si Inc.
Material findings
from the full read of every filingEvery document this company files gets read whole — body and exhibits. These are the ones the read flagged as material, newest first, each citing its filing.
The Proteus launch has moved from end-2026 to Q2 2027 as the company states it. This summary is drawn from the cover page and cautionary note; the financial statements are not covered here.
The launch slipped roughly three quarters and the runway extended two quarters, and the second is bought with the 20% headcount cut rather than with new capital — $169.9 million against guided cash usage of up to $93.0 million a year is what makes the arithmetic work. The $4 billion market figure is the company's own estimate, not a measured market.
The Company has an initial 180 calendar days, until January 19, 2027, to regain compliance by closing at $1.00 or more for at least 10 consecutive business days, subject to Staff discretion to extend that ten-day period. A second 180-day period is available only if the Company transfers its listing to The Nasdaq Capital Market, meets the market value of publicly held shares requirement and all other initial listing standards, pays an application fee and states in writing that it will cure by reverse split if necessary.
This is a long-dated fixed cost being locked in by a pre-revenue instrument company: about $3.78 million of base rent in the first year alone, escalating 3% annually, beginning no later than November 1, 2027. For a company funding operations from its balance sheet, committing to a facility of that size signals confidence in scaling the Proteus platform, and it also converts flexibility into a fixed obligation that must be serviced whether or not commercial traction arrives.
Two amendments to the same registration statement on one day, carrying the same registered amounts and the same fee, means whatever this version changes is not in the cover or the fee table. The Class A figure still assumes a June 15, 2021 closing and Quantum-Si's capitalisation as of May 1, 2021, and the $15.96 price is still the February 23, 2021 high-low average taken within five business days of the initial registration statement — nearly three months old by this filing. Quantum-Si's Series A preferred holders take the Class B, which converts one-for-one into Class A.
The Class A count is explicitly conditional: it assumes a closing date of June 15, 2021 and is based on Quantum-Si shares outstanding as of May 1, 2021, so it moves if either changes. Quantum-Si's Series A preferred holders take 19,862,500 shares of a separate New Quantum-Si Class B class that converts one-for-one into Class A, which is why the fee table prices both at $15.96. That $15.96 is the February 23, 2021 high-low average, carried forward from the initial registration statement rather than refreshed for this amendment.
Show 3 more material filings
Quantum-Si's Series A preferred holders take 20,070,000 shares of a separate New Quantum-Si Class B class that converts one-for-one into Class A, which is why the fee table prices both at the same $15.96 and registers the underlying Class A at no additional fee. The remaining 66,009,275 Class A shares go to holders of Quantum-Si common stock, its Series B through Series E preferred, and shares issuable on options exercised before closing. The $15.96 is the February 23, 2021 high-low average, taken against the initial registration statement rather than this amendment.
Which series a holder owns decides which class they end up in: Quantum-Si's common stock and its Series B, C, D and E preferred convert into Class A, while its Series A preferred alone converts into 20,070,000 shares of Class B, which is itself convertible one-for-one into Class A. Shares issuable on options exercisable before the closing sit inside the Class A figure as well. Both classes are priced at $15.96 for fee purposes, on HighCape Class A trading of February 23, 2021, and the registration fee was previously paid.
The two Class A counts in this filing disagree: the fee table registers 66,009,275 shares while the prospectus cover offers 58,260,189, and the document does not reconcile them. The Class A figure assumes a closing date of May 15, 2021 and Quantum-Si's shares outstanding as of February 1, 2021, covering common stock, Series B through Series E preferred and shares issuable on options exercisable before closing. Quantum-Si's Series A preferred alone takes the 20,070,000 Class B shares, each convertible into one Class A share.
Filings
live EDGAR feedEverything this company has filed with the SEC recently, newest first, each with a plain summary of what changed and why it matters.
What changed: Q2 2026 10-Q of Quantum-Si Incorporated (Nasdaq: QSI). The cautionary note states that the company's Proteus platform, originally anticipated to be launched at the end of 2026, is now estimated to be commercially available in the second quarter of 2027, and warns that a launch outside that updated time frame, or one lacking the applications customers seek, could materially affect long-term financial success and market credibility, and that the pending launch may slow purchasing decisions for existing instruments and consumables. Why it matters: The Proteus launch has moved from end-2026 to Q2 2027 as the company states it. This summary is drawn from the cover page and cautionary note; the financial statements are not covered here.
What changed: Quantum-Si Incorporated (Nasdaq: QSI) furnished a press release dated August 13, 2026 reporting second quarter 2026 results and a Proteus development update. Revenue was $344 thousand against $591 thousand a year earlier and $602 thousand for the six months against $1.4 million, with gross margin of 50% in the quarter and 41% for the six months. Total operating expenses were $25.8 million against $30.5 million and the net loss $23.5 million against $28.8 million; for the six months the net loss was $45.2 million against $48.0 million. Why it matters: The launch slipped roughly three quarters and the runway extended two quarters, and the second is bought with the 20% headcount cut rather than with new capital — $169.9 million against guided cash usage of up to $93.0 million a year is what makes the arithmetic work. The $4 billion market figure is the company's own estimate, not a measured market.
What changed: 8-K of Quantum-Si Incorporated. Item 3.01 (notice of delisting or failure to satisfy a continued listing standard): on July 23, 2026 the Company received written notice from Nasdaq Listing Qualifications that, because the closing bid price of its Class A common stock has been below $1.00 for 30 consecutive business days, it no longer meets the minimum bid price requirement for continued inclusion on The Nasdaq Global Market under Listing Rule 5450(a)(1). The notice has no immediate effect on listing or trading, which continues on the Global Market under QSI. Why it matters: The Company has an initial 180 calendar days, until January 19, 2027, to regain compliance by closing at $1.00 or more for at least 10 consecutive business days, subject to Staff discretion to extend that ten-day period. A second 180-day period is available only if the Company transfers its listing to The Nasdaq Capital Market, meets the market value of publicly held shares requirement and all other initial listing standards, pays an application fee and states in writing that it will cure by reverse split if necessary.
Show the other 10 filings
What changed: Item 1.01: on June 18, 2026 Quantum-Si, Incorporated entered into a lease with Sterling City Science South Development, LLC for approximately 54,374 square feet of planned office, laboratory and manufacturing space at 9955 Pacific Heights Boulevard, San Diego, to replace existing space expiring December 31, 2027. Initial monthly base rent is approximately $315,369.20, or $5.80 per square foot, for the first 12-month term, rising by approximately 3% each subsequent 12-month period. The term commences no later than November 1, 2027, with an option to extend for one additional five-year period. Why it matters: This is a long-dated fixed cost being locked in by a pre-revenue instrument company: about $3.78 million of base rent in the first year alone, escalating 3% annually, beginning no later than November 1, 2027. For a company funding operations from its balance sheet, committing to a facility of that size signals confidence in scaling the Proteus platform, and it also converts flexibility into a fixed obligation that must be serviced whether or not commercial traction arrives.
The sponsor
The people who set this company up, what they have done before, and the advisers around the deal.
HighCape Capital Acquisition LLCnamed as sponsor in this SPAC’s filings — but with no researched track record behind it yet.
A missing score, not a score of zero — why
A Sponsor Score is only published once the sponsor’s prior vehicles have been verified on EDGAR and their post-close outcomes priced. That record does not exist for this sponsor yet, so no number and no tier is shown. That is a missing score, not a score of zero — and not a neutral 50 either.
Coverage so far: 301 of 1283 tracked SPACs (23%) are attached to a scored sponsor. This card fills in by itself as the research lands.
The record
The reference detail — how the shares were structured at listing, how thinly they trade, and where the company is registered.
Show the reference detail
Unit structure
from 424B3 0001140361-25-039703
Trading & liquidity
Company profile
Directors & officers
- Fattori Ruth ADirector
- LaPointe ChristianGC & Corp. Secretary
- Keyes Jeffry R.Chief Financial Officer
- Vieceli John S.Chief Product Officer
- Hawkins Jeffrey AlanDirector
- Makes BrigidDirector
- Jafri AmirDirector
- Dowdy PaulaDirector
Institutional holders
from SC 13G/13DFunds that have declared a stake above 5%. Heavy ownership by arbitrage funds usually means heavy cash-outs at the next vote.
Show the declared stakes
13 filers with a stake on file · 0 re-affirmed in the last 12 months. A stake with no amendment since is the filer’s last word on it, not proof it is still held — and percentages filed in different years are percentages of different floats, because this vehicle’s share count collapses at every redemption.
- ROTHBERG JONATHAN Mwith 4 other reporting persons on the same schedule90.0% · SC 13D/ASep 17, 2024 stale
- HighCape Capital Acquisition LLCwith 1 other reporting person on the same schedule21.6% · SC 13DSep 15, 2020 stale
- ARK Investment Management LLC12.7% · SC 13G/AJan 29, 2024 stale
- Nikko Asset Management Americas, Inc.7.0% · SC 13GFeb 13, 2024 stale
- Sumitomo Mitsui Trust Holdings, Inc.with 1 other reporting person on the same schedule7.0% · SC 13GFeb 5, 2024 stale
- BlackRock Inc.6.1% · SC 13G/AJan 29, 2024 stale
- Foresite Capital Fund IV, L.P.with 6 other reporting persons on the same schedule3.7% · SC 13D/AJun 28, 2022 stale
- GLENVIEW CAPITAL MANAGEMENT, LLCwith 1 other reporting person on the same schedule3.5% · SC 13G/AFeb 14, 2023 stale
- Flynn James Ewith 3 other reporting persons on the same schedule1.7% · SC 13D/AJun 14, 2021 stale
- Radcliffe Capital Management, L.P.with 5 other reporting persons on the same schedule0.0% · SC 13G/AJun 28, 2024 stale
- GLAZER CAPITAL, LLCwith 1 other reporting person on the same schedule0.0% · SC 13G/AFeb 14, 2022 stale
- Polar Asset Management Partners Inc.0.0% · SC 13G/AFeb 9, 2022 stale
- Linden Capital L.P.with 2 other reporting persons on the same schedule0.0% · SC 13G/AJan 28, 2022 stale
One line per filer, not per reporting person: a joint schedule names the management company, its funds and often the individual who controls them, and all of them report the same shares. Click a name for that filer’s whole footprint across every SPAC it has declared a stake in.
Sources on file
harvested pages, kept in fullEvery public page we have read about this company, stored in full so a source can never go missing.
Show the sources
31 full SEC filing texts archived — searchable, never lost.
- Vault note — CAPA (HighCape Capital Acquisition Corp.)
vault-note · /vault/tickers/CAPA
- Vault deal note — Quantum-Si Inc (CAPA)
vault-note · /vault/deals/quantum-si-inc
- Ihre Datenschutzeinstellungen
news · consent.yahoo.com
- Ihre Datenschutzeinstellungen
news · consent.yahoo.com
- Ihre Datenschutzeinstellungen
news · consent.yahoo.com
- Single-Molecule Protein Sequencing Technology | Quantum-Si
company-site · quantum-si.com
- Platinum® Pro Next-Generation Protein Sequencer | Quantum-Si
company-site · quantum-si.com
- Proteomics Platforms | Quantum-Si
company-site · quantum-si.com
- Single-Molecule Protein Sequencing Solutions | Quantum-Si
company-site · quantum-si.com
In plain English
tap a term to open itEvery piece of jargon this page could have used, and what it actually means.
Open the plain-English guide
No floor / floorlessthe cash guarantee is gone — the price is unprotected
A SPAC's downside protection is not the cash in trust; it is your right to demand that cash. Once the redemption window closes, the cash stays with the company and the share can trade anywhere.
Redemption deadlinethe last day to hand shares back for cash
Set by the filing that calls the meeting. Tender after it and the company is under no obligation to pay you the trust value.
Broker action datethe day your broker needs the instruction — earlier than the official date
Brokers batch redemption instructions to the transfer agent, so the practical cutoff is roughly two business days before the published deadline. This is the date that actually costs people the floor.
Cash in trust / trust per sharethe cash the company is holding for each public share
Filed quarterly in the 10-Q's XBRL. It earns interest between filings, so the figure on a given day is slightly higher than the last filed one — where we show that we label it an estimate.
Trust discountbuying below the cash held for you
Only meaningful while a redemption right exists. On a floorless name the same arithmetic is not a discount, it is the market pricing distress, and this product will not call it a yield.
Dilutionhow much of the company new shares take from you
Sponsor promote, PIPE shares, warrants and rights all issue stock that did not pay $10 for it. The headline deal value is before that; the effective value is after.
Pro-forma equitywhat the company is valued at once the deal closes
The combined company's equity value assuming the announced terms and the redemptions that have actually happened.
ARShow much upside you get per unit of downside
SpacBrain's asymmetric-return score. It is deterministic — the same inputs always produce the same number — and it is capped, not zeroed, when the floor is gone.
De-SPACthe day the SPAC becomes the real company
The shares stop being a claim on a pot of cash and start being equity in an operating business. Roughly 80% of recent de-SPACs traded below $10 within a year.
Outside datethe contractual long-stop for closing the deal
A deadline between the SPAC and its target, not between the SPAC and you. It confers no right to cash, which is exactly why it must never be counted as a redemption window.
Accession numberthe SEC's unique id for one filing
Every figure on this page carries the accession of the filing that states it, so you can open the primary document rather than trust us.
Accreted NAV (estimate)the last filed cash figure, plus the interest it should have earned since
A model, not a filing: last filed value compounded at the 3-month T-bill for the days elapsed. Always shown in italic with the word estimate, and never printed beside a filed number without it.
Ask the brain
from its filingsData provenance & audit trail4 internal entries
Written by SpacBrain’s data agents whenever a figure is captured, corrected or flagged, and kept verbatim so every number on this page can be traced back to the filing that states it. This is a running log, not the current record: an early entry may be superseded by a later correction — the panels above always hold the current values.
admitted from EDGAR's QUARTERLY FORM INDEX, walked without any SIC filter. The SIC 6770 census could not reach this registrant: EDGAR reassigns a shell's SIC the day it stops being one, and this CIK now files under 3829 (Measuring & Controlling Devices, NEC). The screen found it by filing SHAPE instead — S-1 2020-08-03 → 8-A12B 2020-09-02 → 424B4 2020-09-04 — which nothing rewrites. Admission rule: src/lib/universe-admit.ts. SIC 3829 + self-described blank check in 424B4 0001104659-20-102606; 424B 0001104659-20-102606 priced 2020-09-04 under S-1 0001104659-20-089244 (file 333-240283, an offering for cash); common ticker CAPA off 10-Q 0001104659-21-071318 (2021-05-24); lifecycle EXITED. The pricing prospectus was filed under SEC file number 333-240283, which belongs to S-1 0001104659-20-089244 (2020-08-03) — a registration of shares sold for CASH, which is what makes it an IPO rather than merger consideration. Blank-check status from the registrant's own first-person sentence in that prospectus (EDGAR full-text search, 424B4 2020-09-04). Ending PROVEN, not inferred: CLOSED per 8-K 0001104659-21-081560 (2021-06-15) — 8-K item 5.06 "Change in Shell Company Status" (EDGAR item index, items: 1.01,2.01,3.02,3.03,4.01,5.01,5.02,5.06,9.01). EDGAR now files this CIK as "Quantum-Si Inc" — the SPAC's own name is kept here and the successor is the target. ipoSizeM and deadline left NULL: gross-proceeds prose conflates the over-allotment with the offering, and a charter deadline belonging to a vehicle that has ended is a date nobody can act on. ipoDate is the 424B pricing date.
sponsor "HighCape Capital Acquisition LLC" sourced from prospectus definition (10-K/A) acc 0001104659-21-063949.
[CLOSED-RENAME] EDGAR CIK 0001816431 records "HighCape Capital Acquisition Corp." ending 2021-06-10; the registrant continues as "Quantum-Si Inc". The rename is the SEC's own record of what the vehicle became, keyed by CIK. Closed 2021-06-10. No deal value is set — a rename says what was acquired, never for how much. No date column is set: Deal has announcedAt, voteDate and expectedCloseAt and nowhere to record an actual close, so the SEC's date is kept here until that column exists. [DEAL-STRUCTURE-MINED] pipeSizeM=425, terminationFeeM=11 from primary filings (0001104659-21-029881, 0001816431-25-000060).
pipeBasis set to UNSOURCED: the size came from the research seed / an earlier record and no filing we hold states it — surfaces now label it "unsourced"; an LLM re-read to FILED replaces this when credits allow